4.2

Wearable Neurostimulation Clinical Trial Part 2

 

About Our Guest

The data behind Spark Biomedical’s Sparrow Therapy System™ speaks volumes, but personal patient experiences speak even louder. Host Daniel Litwin and guest Dr. Carlos Tirado, MD, MPH review sound bites from Eliza, one of the Sparrow Therapy System clinical trial users, as she detailed her personal experience.

transcript
View Transcript

Episode Overview

The data behind Spark Biomedical’s Sparrow Therapy System™ speaks volumes, but personal patient experiences speak even louder. Host Daniel Litwin and guest Dr. Carlos Tirado, MD, MPH review sound bites from Eliza, one of the Sparrow Therapy System clinical trial users, as she detailed her personal experience.

In describing her experience with the Sparrow Therapy System, Eliza notes, “You don’t have to worry about waking up in the morning and waiting for our taper and getting sick and all this other stuff,” she stated. “It’s already helping you physically and mentally was one of the things I noticed. I didn’t feel foggy from the other paper meds, I just felt clear.”

Dr. Tirado explains, “Because this it is a non-invasive, non-medical or non-pharmacologic approach, you’re not having to deal with the known adverse effects of medications that are used to treat withdrawal, or you can reduce the amount of medications used to treat withdrawal.” By reducing or eliminating taper medications, individuals can begin to participate in the hard work of therapy sooner — at a time they would normally be focused heavily on withdrawal symptoms.

Eliza stated, “By day two, I wasn’t even really thinking about my withdrawals and so I think that’s probably what surprised me the most.”

Removing fear of withdrawal from the recovery equation is critical. Dr. Tirado noted, “That true self is someone who is relieved of those symptoms, who can actually start making the next right decision,” he added.

Currently, the Sparrow Therapy System is already being used by opioid use disorder treatment providers across the northeast and southern U.S. to treat opioid withdrawal. Spark Biomedical recently obtained a National Institute on Drug Abuse (NIDA) grant for the Sparrow Ascent, the next generation Sparrow Therapy system, to be used in the RESTORE clinical trial focused on using Transcutaneous Auricular Neurostimulation to improve relapse prevention in opioid use disorder.

To learn more about the Sparrow Therapy System visit sparkbiomedical.com.

Host: Daniel J. Litwin

Guest: Dr. Carlos Tirado, MD, MPH

Don't miss out. Subscribe to be alerted to future episodes and special events.

Download the Updated Clinical Trial Whitepaper
Download Today